165 related articles for article (PubMed ID: 34675134)
21. Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma.
Li AL; Zhu YM; Gao LQ; Wei SY; Wang MT; Ma Q; Zheng YY; Li JH; Wang QF
Anal Cell Pathol (Amst); 2021; 2021():4743971. PubMed ID: 33511023
[TBL] [Abstract][Full Text] [Related]
22. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
Sasse AD; Sasse EC; Clark LG; Ulloa L; Clark OA
Cochrane Database Syst Rev; 2007 Jan; (1):CD005413. PubMed ID: 17253556
[TBL] [Abstract][Full Text] [Related]
23. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
[TBL] [Abstract][Full Text] [Related]
24. Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
Ugurel S; Schrama D; Keller G; Schadendorf D; Bröcker EB; Houben R; Zapatka M; Fink W; Kaufman HL; Becker JC
Cancer Immunol Immunother; 2008 May; 57(5):685-91. PubMed ID: 17909797
[TBL] [Abstract][Full Text] [Related]
25. The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.
Donia M; Kimper-Karl ML; Høyer KL; Bastholt L; Schmidt H; Svane IM
Eur J Cancer; 2017 Mar; 74():89-95. PubMed ID: 28335891
[TBL] [Abstract][Full Text] [Related]
26. Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
Dummer R; Ascierto PA; Gogas HJ; Arance A; Mandala M; Liszkay G; Garbe C; Schadendorf D; Krajsova I; Gutzmer R; Chiarion Sileni V; Dutriaux C; de Groot JWB; Yamazaki N; Loquai C; Moutouh-de Parseval LA; Pickard MD; Sandor V; Robert C; Flaherty KT
Lancet Oncol; 2018 Oct; 19(10):1315-1327. PubMed ID: 30219628
[TBL] [Abstract][Full Text] [Related]
27. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
Yang S; Xu J; Zeng X
Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
[TBL] [Abstract][Full Text] [Related]
28. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
[TBL] [Abstract][Full Text] [Related]
29. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
30. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.
Robbins PF; Morgan RA; Feldman SA; Yang JC; Sherry RM; Dudley ME; Wunderlich JR; Nahvi AV; Helman LJ; Mackall CL; Kammula US; Hughes MS; Restifo NP; Raffeld M; Lee CC; Levy CL; Li YF; El-Gamil M; Schwarz SL; Laurencot C; Rosenberg SA
J Clin Oncol; 2011 Mar; 29(7):917-24. PubMed ID: 21282551
[TBL] [Abstract][Full Text] [Related]
31. Metastatic malignant melanoma.
Markovic SN; Erickson LA; Flotte TJ; Kottschade LA; McWilliams RR; Jakub JW; Farley DR; Tran NV; Schild SE; Olivier KR; Vuk-Pavlovic S; Sekulic A; Weenig RH; Pulido JS; Quevedo JF; Vile RG; Wiseman GA; Stoian I; Pittelkow MR;
G Ital Dermatol Venereol; 2009 Feb; 144(1):1-26. PubMed ID: 19218908
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
Front Immunol; 2021; 12():659444. PubMed ID: 34040608
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract][Full Text] [Related]
34. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ
Elife; 2019 Jun; 8():. PubMed ID: 31169496
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
36. The Emerging Therapeutic Landscape of Advanced Melanoma.
Henriques V; Martins T; Link W; Ferreira BI
Curr Pharm Des; 2018; 24(5):549-558. PubMed ID: 29366407
[TBL] [Abstract][Full Text] [Related]
37. Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Guttà C; Rahman A; Aura C; Dynoodt P; Charles EM; Hirschenhahn E; Joseph J; Wouters J; de Chaumont C; Rafferty M; Warren M; van den Oord JJ; Gallagher WM; Rehm M
Cell Death Dis; 2020 Feb; 11(2):124. PubMed ID: 32054850
[TBL] [Abstract][Full Text] [Related]
38. Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate.
Vilella R; Benítez D; Milà J; Lozano M; Vilana R; Pomes J; Tomas X; Costa J; Vilalta A; Malvehy J; Puig S; Mellado B; Martí R; Castel T
Cancer Immunol Immunother; 2004 Jul; 53(7):651-8. PubMed ID: 14999431
[TBL] [Abstract][Full Text] [Related]
39. [Advances in immunotherapy for metastatic melanoma].
Oláh J
Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
[TBL] [Abstract][Full Text] [Related]
40. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
